Due to necessary maintenance, Xenbase will be unavailable December 24-30, 2014. We apologize for the inconvenience.

Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Acta Pharmacol Sin. May 1, 2004; 25 (5): 554-60.

Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.

Yang BF , Xu DH , Xu CQ , Li Z , Du ZM , Wang HZ , Dong DL .

To determine the mechanisms of interactions between different drugs and HERG channels.Various antiarrhythmic (dofetilide, quinidine, azimilide, RP58866) and non-antiarrhythmic (terfenadine, nicotine) agents were used on HERG channels expressed in Xenopus oocyte. Whole-cell voltage-clamp techniques were used.All drugs produced concentration-dependent block of HERG current. The inhibition was markedly facilitated with voltage protocols favoring channel inactivation (eg, less negative holding potentials). Maneuvers that weakened channel inactivation (eg, elevation of external K+), relieved HERG blockade by all drugs. Moreover, the inhibitory potency was reduced by at least 20-300 fold with varying compounds when rapid C-type inactivation was removed by a mutation located between the transmembrane domains 5 and 6 (S631A).The inactivation gating of HERG channels determines the blocking potency of drugs. This mechanism might be common to drugs of various classes.

PubMed ID: 15132818
Article link:

Genes referenced: kcnh2
Antibodies referenced:
Morpholinos referenced:

My Xenbase: [ Log-in / Register ]
version: [3.3.1]

Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556